Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Beta Bionics, Inc. (BBNX) since 2025 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Beta Bionics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1674632.
Total stock buying since 2025: $17,566,950.
Total stock sales since 2025: $728,370.
Total stock option exercises since 2025: $133,404.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 1,033,350 | $17,566,950 | 41,902 | $728,370 | 26,158 | $133,404 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-09 | 0 | $0 | 7,773 | $146,618 | 0 | $0 |
| 2025-08 | 0 | $0 | 26,158 | $438,640 | 26,158 | $133,404 |
| 2025-06 | 0 | $0 | 7,958 | $142,891 | 0 | $0 |
| 2025-01 | 1,033,350 | $17,566,950 | 13 | $221 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-09-02 | Russell Steven Jon (Chief Medical Officer) | Sale | 1,015 | 18.86 | 19,145 |
| 2025-09-02 | Saint Sean (President & CEO) | Sale | 3,359 | 18.86 | 63,360 |
| 2025-09-02 | Feider Stephen (Chief Financial Officer) | Sale | 1,462 | 18.86 | 27,577 |
| 2025-09-02 | Mensinger Mike (Chief Product Officer) | Sale | 1,089 | 18.86 | 20,541 |
| 2025-09-02 | Hopman Mark (Chief Commercial Officer) | Sale | 848 | 18.86 | 15,995 |
| 2025-08-22 | Feider Stephen (Chief Financial Officer) | Sale | 4,413 | 17.01 | 75,082 |
| 2025-08-22 | Feider Stephen (Chief Financial Officer) | Option Ex | 4,413 | 5.10 | 22,506 |
| 2025-08-19 | Feider Stephen (Chief Financial Officer) | Sale | 5,587 | 17.04 | 95,174 |
| 2025-08-19 | Feider Stephen (Chief Financial Officer) | Option Ex | 5,587 | 5.10 | 28,493 |
| 2025-08-19 | Hopman Mark (Chief Commercial Officer) | Sale | 16,158 | 16.61 | 268,384 |
| 2025-08-19 | Hopman Mark (Chief Commercial Officer) | Option Ex | 16,158 | 5.10 | 82,405 |
| 2025-06-02 | Russell Steven Jon (Chief Medical Officer) | Sale | 1,039 | 17.96 | 18,656 |
| 2025-06-02 | Saint Sean (President & CEO) | Sale | 3,439 | 17.96 | 61,750 |
| 2025-06-02 | Feider Stephen (Chief Financial Officer) | Sale | 1,497 | 17.96 | 26,880 |
| 2025-06-02 | Mensinger Mike (Chief Product Officer) | Sale | 1,115 | 17.96 | 20,020 |
| 2025-06-02 | Hopman Mark (Chief Commercial Officer) | Sale | 868 | 17.96 | 15,585 |
| 2025-01-31 | Wellington Hadley Harbor Aggregator Iv, L.p. | Buy | 1,000,000 | 17.00 | 17,000,000 |
| 2025-01-31 | Mensinger Mike (Chief Product Officer) | Buy | 33,350 | 17.00 | 566,950 |
| 2025-01-31 | Mensinger Mike (Chief Product Officer) | Sale | 13 | 17.00 | 221 |
Insider trading activities including stock purchases, stock sales, and option exercises of BBNX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Beta Bionics, Inc. (symbol BBNX, CIK number 1674632) see the Securities and Exchange Commission (SEC) website.